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Abstract 
Background & Aims: The activation of Wnt/β-catenin signaling causes the development 
of gastric and colon cancers. Sox17 represses Wnt/β-catenin signaling and is 
downregulated in colon cancer. This study was designed to elucidate the role of Sox17 
during the course of gastrointestinal tumorigenesis. Methods: Sox17 expression was 
examined in gastrointestinal tumors of mouse models and humans. The roles of Sox17 in 
gastric tumorigenesis were examined by cell culture experiments and by construction of 
Sox17 transgenic mice. Results: Sox17 was induced in K19-Wnt1/C2mE mouse gastric 
tumors and K19-Wnt1 preneoplastic lesions, where Wnt/β-catenin signaling was activated. 
Consistently, Wnt activation induced Sox17 expression in gastric cancer cells. In contrast, 
Sox17 was rarely detected by immunohistochemistry in gastric and colon cancers, while 
strong nuclear staining of Sox17 was found in more than 70% of benign gastric and 
intestinal tumors. Treatment with a demethylating agent induced Sox17 expression in 
gastric cancer cells, thus indicating the downregulation of Sox17 by methylation. Moreover, 
transfection of Sox17 in gastric cancer cells suppressed both the Wnt activity and colony 
formation efficiency. Finally, transgenic expression of Sox17 suppressed dysplastic tumor 
development in K19-Wnt1/C2mE mouse stomach. Conclusions: Sox17 plays a tumor 
suppressor role through suppression of Wnt signaling. However, Sox17 is induced by Wnt 
activation in the early stage of gastrointestinal tumorigenesis, and Sox17 is downregulated 
by methylation during malignant progression. It is therefore conceivable that Sox17 
protects benign tumors from malignant progression at early stage of tumorigenesis, and 
downregulation of Sox17 contributes to malignant progression through promotion of Wnt 
activity. 
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Introduction 
The binding of the Wnt ligand to a Frizzled receptor destabilizes the β-catenin 
degradation complex containing APC, AXIN, and GSK3β, allowing the nuclear 
translocation of β-catenin, followed by the transcriptional activation of the Wnt target 
genes1. This canonical Wnt signaling (Wnt/β-catenin signaling) plays a key role in the 
maintenance of intestinal stem cells and progenitor cells2,3. Moreover, the constitutive 
activation of Wnt/β-catenin signaling causes gastrointestinal tumorigenesis in both 
human4,5 and mice6,7. It has also been shown that β-catenin accumulation, a hallmark of 
Wnt activation, is particularly enhanced in the invasion front and metastasized colon 
cancer cells, suggesting that promotion of Wnt/β-catenin signaling is important for 
malignant progression8. Growth factors PDGF and HGF, as well as inflammatory cytokine 
TNF-α, have been shown to promote Wnt/β-catenin signaling activity in tumor cells9-11. 
On the other hand, downregulation of Wnt antagonists like SFRPs contribute to gastric 
and intestinal tumorigenesis by boosting Wnt/β-catenin signaling activity12-14. These 
results suggest that the enhancement of Wnt activity by the induction of Wnt promoters 
and/or downregulation of Wnt antagonists is important for gastrointestinal carcinogenesis. 
Sox17 and other Sox family members, Sox3, Sox7, and Sox9, have been shown to 
inhibit Wnt/β-catenin signaling15-18. The Sox gene family was first identified by homology 
to the HMG box of the sex-determining gene SRY19. Sox17-null mouse embryos exhibit a 
deficiency of definitive endoderm20, and overexpression of Sox17 in ES cells results in the 
establishment of stable endoderm progenitors21. These results indicate that Sox17 plays a 
key role in definitive endoderm development. On the other hand, Sox17 expression is 
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downregulated in colon cancer cells by promoter methylation22, and the expression of 
Sox17 in colon cancer cells reduces the efficiency of the colony formation22,23. These 
results suggest that Sox17 is a tumor suppressor for colorectal cancer development.   
Activation of Wnt/β-catenin signaling has been demonstrated to cause the 
development of gastric tumors as well as intestinal tumors6,7,24,25. However, Sox17 
expression during the course of gastrointestinal tumorigenesis has not been fully 
investigated yet. We herein show the Sox17 expression to be unexpectedly induced at the 
early stage of gastric and intestinal tumors both in human and mouse models. Sox17 and 
β-catenin have been shown to cooperate to function as a transcription factor in definitive 
endoderm development26,27. Interestingly, we found that Sox17 target genes were induced 
in mouse gastric tumors, thus suggesting that Sox17 plays a role in early tumorigenesis in 
cooperation with β-catenin. Moreover, the transgenic expression of Sox17 in mouse 
stomach suppressed dysplastic tumor development in K19-Wnt1/C2mE mice7. These 
results suggest that Sox17 prevents malignant progression as a tumor suppressor at an 
early stage of tumorigenesis, and downregulation of Sox17 causes tumor progression. 
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Materials and Methods 
Mouse Models 
Construction of ApcΔ716, cis-ApcΔ716 Smad4 (+/-) knockout (cis-ApcΔ716 Smad4), 
K19-Wnt1, K19-C2mE and K19-Wnt1/C2mE (Gan for Gastric neoplasia) mouse models 
has been described previously6,7,28,29. Briefly, ApcΔ716 mice carry a heterozygous mutation 
in the Apc gene which develop intestinal polyps. cis-ApcΔ716 Smad4 mice are compound 
heterozygotes of Apc and Smad4 which develop invasive intestinal adenocarcinoma. 
K19-Wnt1 and K19-C2mE mice express Wnt1 and a combination of Ptgs2 and Ptges, 
respectively, in gastric epithelial cells. K19-Wnt1 mice develop gastric preneoplastic 
lesions, whereas K19-C2mE mice show inflammation-associated metaplastic hyperplasia. 
Gan mice expressing Wnt1, Ptgs2 and Ptges are compound transgenic mice of K19-Wnt1 
and K19-C2mE, which develop dysplastic gastric tumors. To construct K19-Sox17 mice, 
mouse Sox17 cDNA fragment was subcloned into pBluescript (Stratagene, La Jolla, CA) 
with cytokeratin 19 (K19) gene promoter and SV40 poly(A) cassette. The expression 
vector was microinjected into the fertilized eggs of F1 (C3H and C57BL/6) mice to obtain 
K19-Sox17 mice. Two K19-Sox17 lines, #5 and #9, were established, which showed 
similar phenotypes. Accordingly, we herein present the results with line #5. K19-Sox17 
mice were crossed with Gan mice to obtain Gan K19-Sox17 and K19-Sox17/C2mE 
compound mice. The gastric tumors of Gan (n=4), Gan K19-Sox17 (n=3) and 
K19-Sox17/C2mE mice (n=3) were examined at 30 weeks of age. The tumor height was 
measured using histological sections. C57BL/6 mice (CLEA, Japan) were used for RNA 
and protein preparation from stomach and intestines of embryos, pups and adult mice. All 
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animal experiments were carried out according to the protocol approved by the Ethics 
Committees on Animal Experimentation of Kanazawa University. 
Histology and Immunohistochemistry 
Tissues were fixed in 4% paraformaldehyde, embedded and sectioned at 4-µm 
thickness. The sections were stained with H&E, PAS-Alcian blue or processed for 
immunostaining. Human tissue microarrays of gastric cancer and colon cancer (Biomax 
US, Rockville, MD) were used for immunostaining. Antibodies for Sox17 (R&D systems, 
Minneapolis, MN), β-catenin (Sigma, St. Louis, MO), active β-catenin (Millipore, 
Temecula, CA), and Ki-67 (DakoCytomation, Carpinteria, CA) were used as the primary 
antibody. Staining signals were visualized using the Vectorstain Elite Kit (Vector 
Laboratories, Burlingame, CA). The MOM Kit (Vector Laboratories, Burlingame, CA) 
was used to minimize the background staining signals. For fluorescence immunostaining, 
Alexa Fluor 594 or Alexa Fluor 488 antibody (Molecular Probes, Eugene, OR) was used 
as the secondary antibody. Apoptosis was examined using the ApopTag Apoptosis 
Detection Kit (Chemicon). The mean Ki-67 labeling index was calculated by counting 
Ki-67-labeled cells per microscopic field (×200) in 5 fields.  
Microarray Analyses 
Total RNA samples were prepared from either tumors or the normal stomach of 
Gan (n=5), K19-C2mE (n=3), K19-Wnt1 (n=5), or wild-type (n=3) mice at 30 weeks of 
age using RNeasy Mini Kit (QIAGEN, Valencia, CA). The expression profiles of Sox 
family genes were examined with the Affymetrix GeneChip system and Mouse Genome 
430 2.0 Arrays (Affymetrix, Santa Clara, CA). Wild-type sample data were combined in 
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silico in Rosetta Resolver (Rosetta Biosoftware, Seattle, WA) and used as a reference for 
all samples. The expression profile of Sox family genes in human gastric cancer was 
examined using public data30 (NCBI GEO, GSE4007). These expression data were 
transformed to log10 ratios to the average of all normal samples.   
Filter Array Analyses 
Total RNA was prepared from wild-type mouse stomach (n=3) and Gan mouse 
gastric tumors (n=3). The gene expression profiles were examined using the pooled RNA 
samples and Wnt signaling Pathway Oligo GEArray (SABiosciences, Frederick, MD) 
according to the manufacturer's protocol.  
Real-time RT-PCR 
Total RNA was extracted from tissues using ISOGEN (Nippon Gene, Tokyo, 
Japan), reverse transcribed with PrimeScript RT reagent Kit (Takara, Tokyo, Japan), and 
PCR-amplified by ABI Prism 7900HT (Applied Biosystems) using SYBR Premix Ex Taq 
II (Takara, Tokyo, Japan). Primers were purchased (Takara) and primer sequences are 
available upon request. 
Cell Culture Experiments 
Gastric cancer cell lines, AZ521 (Riken Bioresource Center, Tsukuba, Japan) 
Kato-III (Cell Resource Center, Tohoku Univ., Japan), and AGS (ATCC) and colon 
cancer cell line SW-480, and HEK293 cells (ATCC) were cultured in RPMI1640 or 
DMEM supplemented with 10% FBS. To examine the Wnt/β-catenin signaling activity, 
cells were transfected with TOPflash or FOPflash vector (Upstate Biology, Temecula, 
CA), and the luciferase activities were measured using the Luciferase Assay System 
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(Promega, Madison, WI). TOPflash results were normalized with FOPflash. For 
demethylation, cells were treated with 1 µM of 5-aza-2’-deoxycytidine (DAC; Sigma) for 
72 h. For the inhibition of GSK3β and protein synthesis, cells were treated with 
SB-216763 at 10 µM for 24 h and cycloheximide at 0.5 µg/ml (Sigma) for 12 h. For 
activation of Wnt/β-catenin signaling, pcDNA3-S33A-β-catenin, kindly provided by Dr. 
Peter Vogt at the Scripps Research Institute, was transiently transfected as described11. 
The primary gastric epithelial cells were cultured as described29. Immunostaining of the 
primary spheroid cultures were examined using confocal microscopy. For the colony 
formation assay, AGS cells were transfected with the same amount of Sox17 expression 
vector or empty vector (pcDNA3.1-Hygro, Invitrogen, Carlsbad, CA), cultured in 
hygromycin containing medium at 50 µg/ml for 10 days, and then the mean colony 
numbers from 6 independent experiments were thus calculated. 
Immunoblotting Analysis 
Tissue samples were homogenized and sonicated in lysis buffer. After 
centrifugation at 2,000 × g, 10 µg of the protein sample was separated in a 10% 
SDS-polyacrylamide gel. Antibodies for Sox17 (R&D, Minneapolis, MN), active 
β-catenin (Millipore, Temecula, CA), total β-catenin (Sigma, St. Louis, MO), total 
GSK3β (BD Biosciences, San Jose, CA) and phosphorylated GSK3 on Ser9 and 21 (Cell 
Signaling, Danvers, MA) were used as the primary antibody. The ECL detection system 
(GE Healthcare, Buckinghamshire, UK) was used to detect the specific signals. Band 
intensities were measured by Image J (NIH). 
Statistical Analysis 
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The data were analyzed by the unpaired t-test using Microsoft Excel (Microsoft), 
and presented as the mean ± standard deviation (s.d.). A value of P < 0.05 was considered 
to be statistically significant. 
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Results 
Induction of Sox17 in Gan mouse gastric tumors 
We first examined the gene expression profile in gastric tumors developed in 
K19-Wnt1/C2mE (Gan) mice by filter array analysis. Gan mice develop gastric tumors 
caused by simultaneous activation of the Wnt/β-catenin signaling and COX-2/PGE2 
pathway7. As expected, the Wnt target genes, such as Vegfa, Cdx1 and Cd44, were 
upregulated in the Gan mouse tumors (Figure 1A). Interestingly, the expression of Sox17 
was also elevated in Gan mouse tumors. We thus examined expression of all Sox family 
members by microarray analysis (Figure 1B). The expression levels of Sox2, Sox4, Sox7, 
Sox9 and Sox17 increased significantly in the Gan mouse tumors, while those of Sox6, 
Sox10, Sox12 and Sox14 significantly decreased (Figure 1B). Notably, Sox2, Sox7 and 
Sox9 were upregulated also in the inflamed gastric hyperplasia of K19-C2mE mice that 
express Ptgs2 and Ptges in gastric mucosa29, suggesting that these Sox genes were induced 
by PGE2 or PGE2-dependent inflammation. We confirmed significant induction of Sox17 
in Gan mouse tumors by real-time RT-PCR, while Sox17 was not induced in K19-C2mE 
mice (Figure 1C). 
Induction of Sox17 in Wnt-activated gastric epithelial cells 
We next determined the Sox17-expressing cell types by immunostaining. Notably, 
strong nuclear staining of Sox17 was found in Gan mouse gastric tumor cells (Figure 2A). 
In the normal gastric mucosa, Sox17 was detected only in undifferentiated epithelial cells 
in the gland neck. Notably, nuclear Sox17 staining was also detected in the dysplastic 
epithelial cells of K19-Wnt1 gastric preneoplastic lesions where Wnt/β-catenin signaling 
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was activated (Figure 2B). We next examined Sox17 expression in the primary cultured 
gastric tumor cells. Tumor epithelial cells from Gan mouse tumors formed dome-shaped 
spheroid structures on the culture dish, consisting of small epithelial cells (Figure 2C). 
The spheroid cells showed strong accumulation of β-catenin and negative staining of 
Ki-67, suggesting that they were slow-cycling undifferentiated cells. In contrast, 
monolayer cells surrounding the spheroids showed weak β-catenin staining and 
Ki-67-positive. Notably, a strong Sox17 expression was found only in the spheroids. 
These results, taken together, suggest that Sox17 is induced in the Wnt-activated 
undifferentiated epithelial cells.  
The transfection of active β-catenin expression vector caused a significant increase 
in the Sox17 mRNA levels in AGS gastric cancer cells and 293 cells (Figure 2D). 
Moreover, the treatment of 293 cells with GSK3β inhibitor and cycloheximide induced 
Sox17 expression. These results indicate that unphosphorylated (active) β-catenin directly 
induces Sox17 without protein biosynthesis. 
Downregulation of Sox17 in human gastric cancer cells  
We next examined the expression of all Sox family members in human gastric 
cancer using public microarray databases30. Sox2, Sox4 and Sox9 were significantly 
upregulated in human gastric cancer (Figure 3A), which was consistent with the results of 
Gan mice (Figure 1B). In contrast, Sox17 expression was significantly suppressed in 
human gastric cancer. It has been reported that Sox17 expression is suppressed in colon 
cancer by promoter methylation22. We found that treatment with a demethylating agent 
DAC induced Sox17 expression in AGS and AZ521 gastric cancer cells as well as SW480 
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cells (Figure 3B). Accordingly, it is possible that promoter methylation is one of the major 
causes for Sox17 downregulation in gastric cancer cells.  
Suppression of Wnt signaling and tumorigenesis by Sox17 expression 
Sox17 represses Wnt/β-catenin signaling in colon cancer cells22,23. We found that 
transfection of Sox17 expression vector significantly suppressed the β-catenin/TCF 
transcriptional activity in AZ521 cells (Figure 3C). We confirmed by Western blotting 
that Sox17 transfection resulted in a significant decrease of the active β-catenin level in 
different gastric cancer cells Kato-III (Figure 3D). Because phosphorylated GSK3β stayed 
at the similar level after Sox17 transfection, it is possible that Sox17 represses Wnt 
signaling through a GSK3β-independent mechanism. Importantly, the transfection of 
Sox17 in AGS cells significantly suppressed the colony formation efficiency (Figure 3E), 
thus suggesting that downregulation of Sox17 enhances tumorigenicity of gastric cancer 
cells. 
Reciprocal expression pattern of Sox17 in malignant cancers and benign tumors 
We next examined the Sox17 expression in gastric cancer tissue specimens by 
immunohistochemistry using tissue microarrays. Consistent with the microarray results 
(Figure 3A), Sox17 expression was rarely detected in gastric cancer tissues (2.8%), 
whereas clear β-catenin accumulation was detected in the serial sections (Figure 4A and E). 
Gan mouse tumors are in the early stage of tumorigenesis because tumor cells do not form 
soft agar colonies and are not transplantable to immunodeficient mice (data not shown). 
We thus examined whether Sox17 is induced in the benign human gastric tumors. 
Importantly, strong nuclear Sox17 staining was found in 71.4% of gastric tubular 
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adenomas (Figure 4C and E). These results suggest that Sox17 expression is induced at the 
early stage of gastric tumorigenesis, and then downregulated during malignant progression. 
A similar pattern of Sox17 expression was found in colon tumors. Namely, Sox17 was 
rarely detected in colon cancer (2.9%) (Figure 4B and E), while strong nuclear Sox17 
staining was found in 80% of the colon polyps (Figure 4D and E).  
Downregulation of Sox17 during malignant progression of mouse intestinal 
tumors 
We next examined Sox17 expression in mouse intestinal adenomas and 
adenocarcinomas developed in ApcΔ716 and cis-ApcΔ716 Smad4 mice, respectively. ApcΔ716 
mice develop intestinal polyps caused by activation of Wnt signaling6,24, while cis-ApcΔ716 
Smad4 mice develop invasive adenocarcinomas by suppression of the TGF-β pathway in 
addition to Wnt activation28. We found β-catenin accumulation in ApcΔ716 mouse adenoma 
cells, but staining intensity was not uniform; i.e., the distinct strongly stained area and 
moderately stained area were mixed (Figure 5A). Notably, Sox17 was induced in the 
ApcΔ716 polyps including nascent adenomas (Supplementary Figure 1). Interestingly, 
Sox17 staining intensity in polyps was reciprocal to the β-catenin staining pattern, 
suggesting that Sox17 negatively regulates the β-catenin accumulation level in polyps 
(Figure 5A). The similar reciprocal staining intensities of β-catenin and Sox17 was found 
in the non-invasive polyps of cis-ApcΔ716 Smad4 mice (Figure 5B). Importantly, in the 
invasive adenocarcinomas of cis-ApcΔ716 Smad4 mice, Sox17 expression was dramatically 
suppressed, and only a limited number of tumor cells expressed Sox17 (Figure 5C). Such 
suppression of the Sox17 expression was found in 100% (11/11) of invasive 
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adenocarcinomas. These genetic results clearly indicate that Sox17 is induced at the 
initiation stage of intestinal tumorigenesis and dramatically downregulated when tumors 
progress to adenocarcinoma.   
Sox17 induction and Wnt activation during development of gastrointestinal tract 
Sox17 plays a key role in the definitive endoderm development in cooperation with 
β-catenin20,26,27, which gives rise to gut formation. Interestingly, Sox17 expression was 
also found in the gastrointestinal tract of embryos and pups until 3 weeks of age and then 
downregulated in adult mice (Figure 6A). Notably, the active β-catenin levels in the 
stomach and intestine were significantly higher during the developmental stages compared 
with those in adult mice (Figure 6B). These results suggest a cooperative role of Wnt and 
Sox17 during the development of the gastrointestinal tract. We next examined the 
expression of Sox17-target endoderm markers in Gan mouse gastric tumors by real-time 
RT-PCR. Notably, expression of Foxa1, Cxcr4, Gata3, Krt8 and Ihh were increased 
significantly in Gan mouse tumor tissues compared with that in the wild-type mouse 
stomach (Figure 6C). The expression of these genes are induced in Sox17-transfected 
human ES cells or suppressed in Sox17-null mouse embryos20,21. Accordingly, it is 
possible that cooperation of Sox17 and Wnt/β-catenin signaling plays a role also in tumor 
development through induction of target molecules that function in gastrointestinal 
development. 
Suppression of gastric tumor development by transgenic expression of Sox17 
To investigate the role of Sox17 in gastric tumorigenesis, we constructed Sox17 
transgenic mice (K19-Sox17 mice) using a K19 promoter (Figure 7A). We confirmed an 
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increased Sox17 level in K19-Sox17 mouse gastric mucosa by western blotting and 
immunohistochemistry (Figure 7B and C). Although Sox17-expressing gastric epithelial 
cells increased, histology of the K19-Sox17 mouse stomach was normal (Figure 7C). We 
thus crossed K19-Sox17 mice with Gan mice to construct Gan K19-Sox17 compound 
transgenic mice. We confirmed the transgenic expression of Ptgs2 and Ptges in both Gan 
and Gan K19-Sox17 mouse stomach at similar levels (Supplementary Figure 2), which 
ruled out the possibility of the promoter interference of multiple transgenes. Importantly, 
the expression level of the Wnt target genes, Cd44 and Ephb3, in the Gan K19-Sox17 
mice decreased significantly when compared with that in the Gan mice (Figure 7D), 
indicating suppression of Wnt/β-catenin signaling by Sox17 expression. Moreover, the 
mean height of the gastric tumors in Gan K19-Sox17 mice decreased significantly to 
approximately 30% of that in the age-matched Gan mice (Figure 7E). Apoptotic cells 
were found on the tumor surface of both Gan and Gan K19-Sox17 tumors at similar levels 
(Figure 7F). However, apoptosis was not detected in the intratumoral tissue specimens of 
both genotypes. On the other hand, the Ki-67-labeling index decreased significantly in the 
Gan K19-Sox17 tumors (Figure 7F). These results suggest that Sox17 suppressed tumor 
development through the inhibition of cell proliferation rather than due to the induction of 
apoptosis. 
Suppression of dysplastic tumor phenotype by transgenic expression of Sox17 
Histologically, Gan mouse gastric tumors consisted of irregularly branching glands 
lined with dysplastic tumor cells, and increased angiogenesis was evident (Figure 8A), 
which was consistent with the previous reports7,32. In gastric tumors of Gan K19-Sox17 
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mice, Ki-67-positive proliferating cells aligned at the gland neck of hyperplastic tumors 
and the number of PAS-Alcian blue-positive mucous cells increased (Figure 8B), which 
were similar to the characteristics of metaplastic hyperplasia of K19-C2mE mice29 (Figure 
8C). Gan mice develop dysplastic tumors caused by simultaneous activation of Wnt and 
PGE2 pathways. Accordingly, it is possible that Sox17 expression suppressed Wnt activity 
to the level insufficient for dysplastic tumor development in Gan K19-Sox17 mice, thus 
resulting in development of a PGE2-dependent gastric phenotype. Moreover, 
K19-Sox17/C2mE mice developed metaplastic hyperplasia but not dysplastic tumors 
(Figure 8D), thus indicating that the induction of Sox17 and PGE2 pathways without the 
activation of Wnt/β-catenin signaling is not sufficient for gastric tumor development.  
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Discussion 
Accumulating evidence indicates that activation of Wnt/β-catenin signaling is one 
of the direct causes of gastric and intestinal tumor development4-7. It has been shown that 
the expression of several Sox family genes, including Sox2, Sox9 and Sox17 are induced 
by Wnt/β-catenin signaling31,33,34. In the present study, we found that activation of Wnt 
signaling causes Sox17 expression in gastric cancer cells and that Sox17 is induced in 
benign gastric tumors. Because Sox17 antagonizes Wnt/β-catenin signaling, it is thus 
conceivable that the Wnt activation level in the early stage of tumorigenesis is partially 
suppressed by Sox17, but is sufficient for benign tumor development. Importantly, 
transgenic expression of Sox17 in the Gan mouse stomach suppressed dysplastic tumor 
formation. Suppression of the dysplastic phenotype of Gan K19-Sox17 mouse tumors is 
possibly caused by repression of Wnt/β-catenin signaling. Namely, overexpression of 
Sox17 suppresses Wnt/β-catenin signaling activity to the level insufficient for tumor 
formation. Therefore, it is possible that Sox17 induction level at early stage of 
tumorigenesis is strictly regulated to maintain the Wnt/β-catenin activity for dysplastic 
tumor development. 
On the other hand, Sox17 expression is dramatically suppressed in most human 
gastric cancer cells possibly through promoter methylation, which may results in increase 
of Wnt/β-catenin signaling activity in comparison to that in benign tumors. We also 
confirmed Sox17 downregulation in human colon cancer tissues. Recently, it has been 
suggested that promotion of Wnt/β-catenin signaling is required for malignant progression 
of colon cancer8. Consistently, we found that Sox17 transfection reduced the colony 
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formation efficiency in gastric cancer cells. Accordingly, it is possible that 
downregulation of Sox17 contributes to malignant behavior through promotion of 
Wnt/β-catenin signaling both in the stomach and colon. Therefore, induction of tumor 
suppressor Sox17 at the early stage of tumorigenesis can be considered as a self-protection 
system against malignant tumor development.  
In the present study, we found drastic changes of Sox17 expression during the 
course of intestinal tumorigenesis in ApcΔ716 and cis-ApcΔ716 Smad4 mice. The previous 
genetic studies indicate that mutations in both Apc and Smad4 cause malignant tumor 
development in the intestine28,35. However, due to the fact that Sox17 downregulation was 
tightly associated with invasive tumor phenotype in cis-ApcΔ716 Smad4 mice, it is 
conceivable that Sox17 suppression in addition to Apc and Smad4 mutations is required 
for malignant progression to adenocarcinoma. Because Sox17 downregulation was found 
only in the cis-ApcΔ716 Smad4 mouse tumors but not in ApcΔ716 polyps, it is possible that 
disruption of the TGF-β pathway contributes to suppression of Sox17 expression.  
Sox17 is required for definitive endoderm development, which gives rise to gut 
formation20,21,26. Moreover, it has been shown that β-catenin is also essential for definitive 
endoderm formation36. We demonstrate here that Sox17 continuously expresses in the 
stomach and intestine during organogenesis. Importantly, Wnt signaling is also activated 
in the gastrointestinal tract of embryonic and neonatal stages. These results suggest that 
cooperation of Sox17 and Wnt/β-catenin pathway plays a role also in the morphogenesis 
of gastrointestinal tract. Dysregulation of morphogen signals, such as Notch, Hh or Wnt, 
in adult tissues often results in pathological conditions, such as tumor development37. We 
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herein show that the Sox17-target genes, which encode molecules that play a role in the 
definitive endoderm development, are induced in Gan mouse tumors. Although Sox17 
induction is not sufficient for tumorigenesis, as found in K19-Sox17 or K19-Sox17/C2mE 
mice, it is possible that the activation of both Wnt- and Sox17-target molecules 
cooperatively causes gastric tumor development. 
In conclusion, Sox17 is induced at the early stage of tumorigenesis caused by 
Wnt/β-catenin activation, and Sox17 together with Wnt/β-catenin signaling may play a 
role in tumor development through induction of target genes. At the same time, Sox17 
may play a preventive role against malignant progression through repression of Wnt 
activity. Therefore, it is conceivable that induction and downregulation of Sox17 
expression is important for tumor initiation and malignant progression, respectively, in the 
course of gastrointestinal tumorigenesis. 
Du YC et al. 
21 
References 
1. Nusse R. Wnt signaling in disease and in development. Cell Res 2005;15:28-32. 
2. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in 
the small intestine of mice lacking Tcf-4. Nat Genet 1998;19:379-383. 
3. van de Wetering M, Sancho E, Verweij C, et al. The β-catenin/TCF-4 complex imposes 
a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-250. 
4. Clements WM, Wang J, Sarnaik A, et al. β-Catenin mutation is a frequent cause of Wnt 
pathway activation in gastric cancer. Cancer Res 2002;62:3503-3506. 
5. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in 
colorectal cancer. Nat Rev Cancer 2001;1:55-67. 
6. Oshima M, Oshima H, Kitagawa K, et al. Loss of Apc heterozygosity and abnormal 
tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc 
Natl Acad Sci USA 1995;92:4482-4486. 
7. Oshima H, Matsunaga A, Fujimura T, et al. Carcinogenesis in mouse stomach by 
simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. 
Gastroenterology 2006;131:1086-1095. 
8. Fodde R, Brabletz T. Wnt/β-catenin signaling in cancer stemness and malignant 
behavior. Curr Opin Cell Biol 2007;19:150-158. 
9. Yang L, Lin C, Liu Z-R. p68 RNA helicase mediates PDGF-induced epithelial 
mesenchymal transition by displacing Axin from β-catenin. Cell 2006;127:139-155. 
10. Rasola A, Fassetta M, De Bacco F, et al. A positive feedback loop between hepatocyte 
growth factor receptor and β-catenin sustains colorectal cancer cell invasive growth. 
Du YC et al. 
22 
Oncogene 2007;26: 1078-1087. 
11. Oguma K, Oshima H, Aoki M, et al. Activated macrophages promote Wnt signalling 
through tumour necrosis factor-α in gastric tumour cells. EMBO J 2008;27:1671-1681. 
12. Taketo MM. Shutting down Wnt signal-activated cancer. Nat Genet 2004;36:320-322. 
13. Suzuki H, Watkins DN, Jair K-W, et al. Epigenetic inactivation of SFRP genes allows 
constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-422. 
14. Nojima M, Suzuki H, Toyota M, et al. Frequent epigenetic inactivation of SFRP genes 
and constitutive activation of Wnt signaling in gastric cancer. Oncogene 
2007;26:4699-4713. 
15. Zhang C, Basta T, Jensen ED, et al. The β-catenin/VegT-regulated early zygotic gene 
Xnr5 is a direct target of SOX3 regulation. Development 2003;130: 5609-5624. 
16. Takash W, Cañizares J, Bonneaud N, et al. SOX7 transcription factor: sequence, 
chromosomal localisation, expression, transactivation and interference with Wnt 
signalling. Nucleic Acid Res 2001;29:4274-4283. 
17. Akiyama H, Lyons JP, Mori-Akiyama Y, et al.  Interactions between Sox9 and 
β-catenin control chondrocyte differentiation. Genes Dev 2004;18:1072-1087. 
18. Zorn AM, Barish GD, Williams BO, et al. Regulation of Wnt signaling by Sox 
proteins: XSox17α/β and XSox3 physically interact with β-catenin. Mol Cell 
1999;4:487-498. 
19. Gubbay J, Collignon J, Koopman P, et al. A gene mapping to the sex-determining 
region of the mouse Y chromosome is a member of a novel family of embryonically 
expressed genes. Nature 1990;346:245-250. 
Du YC et al. 
23 
20. Kanai-Azuma M, Kanai Y, Gad JM, et al. Depletion of definitive gut endoderm in 
Sox17-null mutant mice. Development 2002;129:2367-2379. 
21. Séguin CA, Draper JS, Nagy A, et al. Establishment of endoderm progenitors by SOX 
transcription factor expression in human embryonic stem cells. Cell Stem Cell 
2008;3:182-195. 
22. Zhang W, Glöckner SC, Guo M, et al. Epigenetic inactivation of the canonical Wnt 
antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 
2008;68:2764-2772. 
23. Sinner D, Kordich JJ, Spence JR, et al. Sox17 and Sox4 differentially regulate 
β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 
2007;27:7802-7815. 
24. Oshima H, Oshima M, Kobayashi M, et al. Morphological and molecular processes of 
polyp formation in ApcΔ716 knockout mice. Cancer Res 1997;57:1644-1649. 
25. Harada N, Tamai Y, Ishikawa T, et al. Intestinal polyposis in mice with a dominant 
stable mutation of the β-catenin gene. EMBO J 1999;18: 5931-5942. 
26. Tam PPL, Kanai-Azuma M, Kanai Y. Early endoderm development in vertebrates: 
lineage differentiation and morphogenetic function. Curr Opin Genet Dev 
2003;13:393-400. 
27. Sinner D, Rankin S, Lee M, et al. Sox17 and β-catenin cooperate to regulate the 
transcription of endodermal genes. Development 2004;131:3069-3080. 
28. Takaku K, Oshima M, Miyoshi H, et al. Intestinal tumorigenesis in compound mutant 
mice of both Dpc4 (Smad4) and Apc gene.  Cell 1998;92:645-656. 
Du YC et al. 
24 
29. Oshima H, Oshima M, Inaba K, et al. Hyperplastic gastric tumors induced by activated 
macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23:1669-1678. 
30. Leung SY, Chen X, Chu KM, et al. Phospholipase A2 group IIA expression in gastric 
adenocarcinoma is associated with prolonged survival and less frequent metastasis. 
Proc Natl Acad Sci USA 2002;99:16203-16208. 
31. Blache P, van de Wetering M, Duluc I, et al. SOX9 is an intestine crypt transcription 
factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J 
Cell Biol 2004;166:37-47. 
32. Guo X, Oshima H, Kitamura T, et al. Stromal fibroblasts activated by tumor cells 
promote angiogenesis in mouse gastric cancer. J Biol Chem 2008;283:19864-19871. 
33. Van Raay TJ, Moore KB, Iordanova I, et al. Frizzled 5 signaling governs the neural 
potential of progenitors in the developing Xenopus retina. Neuron 2005;46:23-36. 
34. Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt 
signaling, differentiation, and migration. Genes Dev 2004;18:1385-1390. 
35. Kitamura T, Kometani K, Hashida H, et al. SMAD4-deficient intestinal tumors recruit 
CCR1+ myeloid cells that promote invasion. Nat Genet 2007;39:467-475. 
36. Lickert H, Kutsch S, Kanzler B, et al. Formation of multiple hearts in mice following 
deletion of β-catenin in the embryonic endoderm. Dev Cell 2002;3:171-181. 
37. Gregorieff A and Clevers H. Wnt signaling in the intestinal epithelium: from 
endoderm to cancer. Genes Dev 2005;19:877-890. 




Induction of Sox17 in Gan mouse gastric tumors. (A) Results of filter array analysis of 
Wnt pathway in Gan mouse tumors and wild-type mouse (WT) stomach. Squares indicate 
upregulated genes in Gan tumors, and fold increases are indicated in parentheses. (B) 
Expression profiles of Sox family genes in Gan, K19-C2mE (C2mE), K19-Wnt1 (Wnt1) 
and wild-type (WT) mice. The gene expression levels are shown in log10 ratios to 
wild-type as shown in the cyan-magenta color bars (top) and the mean log10 ratios in Gan 
tumors to the wild-type are shown in bar graph (mean ± s.d) (bottom). (C) The relative 
Sox17 mRNA levels of gastric tissues of indicated genotypes to the wild-type mouse 
stomach (mean ± s.d.). Asterisks in (B, C), P < 0.05 versus wild type mouse stomach.   
 
Figure 2 
Induction of Sox17 in Wnt-activated gastric epithelial cells. (A) Immunostaining for Sox17 
in Gan mouse gastric tumor and wild-type gastric gland. (B) Immunostaining for Sox17 
and β-catenin in serial sections of K19-Wnt1 mouse preneoplastic lesion. Arrows in (A and 
B) indicate tumor cells and dysplastic cells, respectively, while arrowheads in (A) indicate 
normal undifferentiated epithelial cells. Bars indicate 100 µm. (C) Photographs of the 
primary cultured Gan mouse tumor epithelial cells. Arrowheads indicate the place of 
spheroid. Bright field photograph (left), and confocal microscopy photographs of spheroid 
(second from left) and surrounding monolayer cells (third from left) immunostained with 
active β-catenin antibody (green). Double immunostaining for Sox17 (green) and Ki-67 
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(red) (right). Arrows indicate Ki-67 positive cells. (D) The relative Sox17 mRNA levels 
in active β-catenin-transfected cells (blue) and GSK3β inhibitor/cycloheximide-treated 
cells (green) to that in untreated control cells (gray) (mean ± s.d.). Asterisks, P < 0.05. 
 
Figure 3 
Downregulation of Sox17 in human gastric cancer, and suppression of Wnt/β-catenin 
signaling by Sox17 expression. (A) The expression profiles of Sox family genes in human 
gastric caner. Gene expression levels are shown in log10 ratios as shown in cyan-magenta 
color bars (top) and in bar graph (mean ± s.d.) (bottom). (B) The relative expression level 
of Sox17 in DAC-treated cells examined by real-time RT-PCT (mean ± s.d.). (C) The 
relative TCF/β-catenin transcription activity examined by TOPflash/FOPflash assay in 
Sox17-transfected AZ521 cells. The DNA amounts of transfected Sox17 expression vector 
(Sox17) and empty vector (EV) are indicated. (D) Representative Western blotting results 
in control and Sox17-transfected Kato-III cells. β-Actin was used as an internal control. 
The relative band intensities of Sox17 and active β-catenin in the Sox17-transfected cells 
(closed bars) to the control levels (gray bars) are shown in bar graph. (mean ± s.d.) (E) 
The number of colonies of AGS cells transfected with empty vector (EV) or Sox17 
expression vector (Sox17) (mean ± s.d.). Asterisks in (A, B, D and E) P < 0.05. 
 
Figure 4 
Immunohistochemistry for Sox17 in malignant cancers and benign tumors. (A, B) 
Representative H&E staining, and immunostaining for Sox17 and β-catenin in two sets of 
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serial sections from gastric cancer (A) and colon cancer (B) tissue microarrays. Insets 
indicate enlarged images. (C, D) Representative H&E staining and Sox17 immunostaining 
in serial sections of human gastric tubular adenoma (C) and colon polyp (D). N, normal 
mucosa; T, tumor region. Enlarged images of normal and tumor regions (squares) of 
Sox17 immunostaining are shown (right). Bars indicate 100 µm. (E) Ratio of 
Sox17-positive specimens in gastric and colon cancers and benign tumors. 
 
Figure 5 
Downregulation of Sox17 in mouse intestinal adenocarcinomas. (A-C) Immunostaining 
for β-catenin and Sox17 in ApcΔ716 mouse polyps (A), non-invasive polyps of cis-ApcΔ716 
Smad4 mice (B), and invasive adenocarcinomas of cis-ApcΔ716 Smad4 mice (C). H&E 
staining (A-C, left; and C, center), immunostaining for β-catenin (green) (A-B, center) and 
for Sox17 (red) (A-C, right), and counter staining with DAPI (blue) (B-C, right). 
β-Catenin and Sox17 in (A-B, center and right) are double immunostaining using the same 
section. T, tumor area; N, normal mucosa; L, lymphocyte-accumulated area; NC, normal 
crypt; SM, smooth muscle layer; and I, invasion front. Arrows in (A, B) indicate reciprocal 
strong stained area of β-catenin (center) and Sox17 (right). Arrowheads in (C, right) 
indicate remained Sox17-expressing tumor cells. Bars indicate 200 µm in (A-C, left) and 
100 µm in (A-C, center and right).  
 
Figure 6 
Sox17 induction and Wnt activation during gastrointestinal development. (A) Expression 
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of Sox17 in the stomach, small intestine, and colon at the indicated ages examined by 
real-time RT-PCR. Asterisks indicate N/A for standard error bars because of two samples. 
(B) The relative level of active β-catenin in the stomach and small intestine to the adult 
mouse level at the indicated ages measured from band intensities of Western blotting. (C) 
The relative mRNA levels of Foxa1, Cxcr4, Gata3, Krt8 and Ihh examined by real-time 
RT-PCR in Gan tumor tissues (closed bars) to those in wild-type mouse stomach (gray 




Suppression of gastric tumor development by transgenic expression of Sox17. (A) 
Schematic construction of transgenic vector. Pm, PmeI; B, BamHI; Xb, XbaI. (B) Western 
blotting results of Sox17 in gastric mucosa of wild-type (WT), K19-Sox17 (Tg) line #5 and 
#9, normal small intestine (SN) as a negative control, and ApcΔ716 mouse polyps (SP) as a 
positive control. β-Actin was used for internal control. (C) Immunostaining for Sox17 in 
gastric mucosa of wild-type and K19-Sox17 mice. Asterisks indicate localization of 
Sox17-expressing epithelial cells. Bars indicate 100 µm. (D) The relative mRNA levels of 
Cd44 and Ephb3 in Gan (red) and Gan K19-Sox17 mice (blue) to the wild-type level 
(black). Asterisks in (C, D), P < 0.05. (E) Representative photographs of stomach of Gan 
mouse and Gan K19-Sox17 mouse, and the relative tumor height in Gan K19-Sox17 
(Gan/Sox17) to that in Gan mice (mean ± s.d.). (F) Representative photographs for 
apoptotic cells in Gan and Gan K19-Sox17 mouse tumors, and relative Ki-67 labeling 
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index in Gan K19-Sox17 tumors (Gan/Sox17) to that in Gan mouse tumors. Arrowheads 
indicate apoptotic cells on the tumor surface. Asterisks in (E, F), P < 0.05. 
 
Figure 8 
Suppression of dysplastic tumor phenotype by transgenic expression of Sox17. 
Histological examination of gastric tumors in Gan (A), Gan K19-Sox17 (B), K19-C2mE 
(C), and K19-Sox17/C2mE mice (D). H&E (left), Ki-67 immunostaining (center), and 
PAS-Alcian blue staining (right). Asterisks in (A, left) indicate capillary vessels. Asterisks 
in (B-D, center) indicate Ki-67-positive proliferating cells that aligned in gland neck. 
Asterisks and arrowheads in (B-D, right) indicate PAS-positive and Alcian blue-positive 
mucous cells, respectively. Bars indicate 100 µm. 








